Literature DB >> 26895210

Bronchial Paraganglioma with SDHB Deficiency.

M R Ghigna1, P Dorfmuller2, A Crutu3, E Fadel3, V Thomas de Montpréville2.   

Abstract

Though most paragangliomas arise as sporadic tumors, the recent advantages in the genetic screening revealed that about 30 % of paragangliomas are linked to hereditary mutations, such as those involving SDH genes. A 22-year-old woman carrying a left main bronchus tumor underwent surgery in our institution. Her past medical history included a GIST without KIT or PDGFRA mutation. The histological examination revealed a nested proliferation of medium-sized cells expressing neuroendocrine markers (chromogranin A and synaptophysin). The neoplastic cells failed to express SDHB gene product. These findings led us to the final diagnosis of bronchial paraganglioma in the setting of Carney-Stratakis syndrome. Bronchial paragangliomas are exceedingly rare tumors with polymorphous clinical presentation, and usually benign clinical course. Though most paragangliomas are sporadic, some tumors are associated with specific hereditary disease, especially those occurring in young patients or in combination with other neoplasms.

Entities:  

Keywords:  Carney-Stratakis syndrome; Hemoptysis; Paraganglioma

Mesh:

Substances:

Year:  2016        PMID: 26895210     DOI: 10.1007/s12022-016-9422-y

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  27 in total

1.  Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes.

Authors:  C Bauters; M-C Vantyghem; E Leteurtre; M-F Odou; C Mouton; N Porchet; J-L Wemeau; C Proye; P Pigny
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

2.  Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital.

Authors:  M Ariton; C S Juan; T W AvRuskin
Journal:  Endocr Pract       Date:  2000 May-Jun       Impact factor: 3.443

3.  Genetic testing in pheochromocytoma or functional paraganglioma.

Authors:  Laurence Amar; Jérôme Bertherat; Eric Baudin; Christiane Ajzenberg; Brigitte Bressac-de Paillerets; Olivier Chabre; Bernard Chamontin; Brigitte Delemer; Sophie Giraud; Arnaud Murat; Patricia Niccoli-Sire; Stéphane Richard; Vincent Rohmer; Jean-Louis Sadoul; Laurence Strompf; Martin Schlumberger; Xavier Bertagna; Pierre-François Plouin; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

4.  Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.

Authors:  Markku Miettinen; Zeng-Feng Wang; Maarit Sarlomo-Rikala; Czeslaw Osuch; Piotr Rutkowski; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2011-11       Impact factor: 6.394

5.  Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.

Authors:  Diana E Benn; Michael S Croxson; Kathy Tucker; Christopher P Bambach; Anne Louise Richardson; Leigh Delbridge; Peter T Pullan; Jeremy Hammond; Deborah J Marsh; Bruce G Robinson
Journal:  Oncogene       Date:  2003-03-06       Impact factor: 9.867

6.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

7.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

8.  Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.

Authors:  Yuejuan Qin; Li Yao; Elizabeth E King; Kalyan Buddavarapu; Romina E Lenci; E Sandra Chocron; James D Lechleiter; Meghan Sass; Neil Aronin; Francesca Schiavi; Francesca Boaretto; Giuseppe Opocher; Rodrigo A Toledo; Sergio P A Toledo; Charles Stiles; Ricardo C T Aguiar; Patricia L M Dahia
Journal:  Nat Genet       Date:  2010-02-14       Impact factor: 38.330

Review 9.  Pheochromocytoma and extra-adrenal paraganglioma: updates.

Authors:  Arthur S Tischler
Journal:  Arch Pathol Lab Med       Date:  2008-08       Impact factor: 5.534

Review 10.  The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.

Authors:  C A Stratakis; J A Carney
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

View more
  1 in total

1.  Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors.

Authors:  Satoshi Kitazawa; Shunsuke Ebara; Ayumi Ando; Yuji Baba; Yoshinori Satomi; Tomoyoshi Soga; Takahito Hara
Journal:  Oncotarget       Date:  2017-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.